ClinicalTrials.gg
Status unknownNCT04783987Updated Jan 25, 2022

Single and Dual Task Gait Parameters in Children With Specific Learning Difficulties

An observational study in Specific Learning Disorder and Gait, sponsored by Afyonkarahisar Health Sciences University. Status unknown at 1 site in Turkey. Open to participants aged 6 Years to 17 Years. Per ClinicalTrials.gov, last updated 2022-01-25.

Sponsored by Afyonkarahisar Health Sciences University · Observational

The sponsor has not verified this record recently (last verified Jan 2022), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
50
Ages
6 Years to 17 Years
Sex
All
01

Study summary

Children with spesific learning disorders have differences in motor and cognitive abilities compared to normal developing children.

Motor tasks as walking are not just have a motor components and also require a cognitive process to realize. Therefore cognitive abilities may effect motor performance.

In daily life, individuals perform dual or multitasks instead of single tasks naturally. Dual task is defined as the concurrent performance of two tasks that can be performed independently. Also dual tasks may be created from different tasks combinations such as a motor-motor dual task or motor-cognitive dual task.

Therefore, aim of the study is to compare gait parameters with healthy controls in single and dual task conditions in children with Special Learning Difficulties.

Read the detailed description

The fifth edition of the The Diagnostic and Statistical Manual of Mental Disorders (DSM-5) opted for a categorical approach that introduced the Specific Learning Difficulties. Accordingly, it is thought that specific learning difficulties include many characteristics such as genetic risk, environmental risk factors, developmental characteristics, comorbidity and cognitive weaknesses. According to DSM-5, Specific Learning Difficulties are difficulties in using learning and school skills, which last at least six months, and are characterized by the presence of at least one of the following symptoms, despite the necessary attempts:

  1. Slowness and mistakes in reading words
  2. Difficulties in reading comprehension
  3. Problems with spelling
  4. Written expression difficulties
  5. Number perception and calculation problems experienced
  6. Numerical reasoning problems. In the literature, there are explanations about many cognitive limitations in children with specific learning difficulties, such as information processing, perceptual motor skills, processing of visual stimuli, phonological approach and the theory of cerebellum disorder. All of these cognitive limitations can also affect the dual task performance of these children.

In daily life, individuals perform dual or multitasks instead of single tasks naturally. Dual task is defined as the concurrent performance of two tasks that can be performed independently. Also dual tasks may be created from different tasks combinations such as a motor-motor dual task or motor-cognitive dual task.

However, no study investigating the effect of specific learning difficulties on walking parameters in single and dual task conditions has been found. In the light of the information is obtained from the literature, the gait parameters of children diagnosed with specific learning difficulties in single and dual task conditions may differ from the healthy control group. Therefore, this study's primary goal is to compare gait parameters in single and dual task conditions in children with Special Learning Disabilities with healthy controls.

02

Conditions studied

  • Specific Learning Disorder
  • Gait
03

In context

Specific Learning Disorder

24 studies on the registry are indexed under Specific Learning Disorder; 4 are open to participants now.

Browse Specific Learning Disorder studies →

Lead sponsor

Afyonkarahisar Health Sciences University is the lead sponsor of 115 studies on the registry; 32 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 17 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

The case group of children between the ages of 6-17 who has been diagnosed with Specific Learning Difficulty and who attends the Specific Learning Difficulty Support Education Program of the Ministry of National Education regularly twice a week; It is planned that a healthy children between the ages of 6-17 will form the control group.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Case Group

  • To be in the age range of 6-17
  • To have a diagnosis of special learning disability Control Group
  • To be in the age range of 6-17
  • To be physically, mentally and psychologically healthy

Exclusion criteria

Exclusion Criteria:

  • Any acute or chronic orthopedic or neurological disease that may affect walking performance,
  • Any surgery within the last 6 months,
  • A hearing impairment that cannot be corrected with a hearing aid
  • A visual impairment that cannot be corrected with glasses.
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
50 participants (estimated)
Patient registry
No

Groups and cohorts

  • Healthy Control Group

    Walking Assessments will be practised under dual and single task conditions.

    Other: Walking asessments

  • Case Group

    Walking Assessments will be practised under dual and single task conditions.

    Other: Walking asessments

Interventions

  • OtherWalking asessments

    Gait parameters will be evaluated in single and dual task conditions with 10 Meter Walk Test and wireless digital miniature portable walking and movement analyzer.

    Also known as: 10 meter walking Test

06

What researchers measure

Primary outcomes

  1. Gait speed

    The time it takes to walk a specified distance

    Time frame: 15 minutes

  2. Cadance

    number of steps per minute

    Time frame: 15 minutes

  3. Strength length

    It is the distance between points where the same heel touches the ground twice in a row.

    Time frame: 15 minutes

07

Study locations

1 of 1 sites recruiting
  • Afyonkarahisar Health Science University
    Afyonkarahisar, 03030, Turkey
    Recruiting
    • EMEL TAŞVURAN HORATA, PhD · Contactethorata@gmail.com · 05547759663
    • Emel TAŞVURAN HORATA, PhD · Principal investigator
    • Yunus Emre KUNDAKCI, PhD · Sub investigator
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Feb 2021 (actual). Primary completion is estimated for Aug 2022, 18 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 2, 2021
First posted
Mar 5, 2021
StartActual
Feb 1, 2021
Primary completionEst.
Aug 2022
CompletionEst.
Aug 2022
Last update
Jan 25, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 25, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04783987
Responsible party
Emel Taşvuran Horata (PhD; Assistant Professor, Afyonkarahisar Health Sciences University) — Principal investigator
First posted
Mar 5, 2021
Start date
Feb 1, 2021
Primary completion
Aug 2022 (estimated)
Completion
Aug 2022 (estimated)
Last update
Jan 25, 2022

Study contacts

EMEL TAŞVURAN HORATA, PhD
Contact
ethorata@gmail.com
05547759663
Emel TAŞVURAN HORATA, PhD
principal investigator · Afyonkarahisar Health Science University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion